OptiMAL®: the antibody library you need for development success
Currently in development, OptiMAL® is Fusion’s new mammalian antibody library – a discovery platform yielding fully human antibodies.
OptiMAL® is for clients looking to streamline the discovery and preclinical optimization of novel antibodies. Incorporating Fusion Antibodies’ proprietary protein engineering technologies, the library eliminates the need for platform switching and reformatting common with other approaches. The output from OptiMAL® is a fully-human antibody with no need for further humanisation.
OptiMAL® is currently being used in four exciting proof of concept studies. Contact us for more information and monitor our news section for further updates.